Texas Deepens Puberty-Blocker Probe Into Endo And AbbVie
Texas is continuing an investigation into Endo's and AbbVie's hormone-blocking drugs the state says are wrongly being used to treat children with gender dysphoria, less than two weeks after a judge...To view the full article, register now.
Already a subscriber? Click here to view full article